Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Fine & Speciality Chemicals
Return to: PBR Home | Production & Manufacturing | Fine & Speciality Chemicals

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News INVISTA, SilicoLife to develop new technologies for bio-derived processes By PBR Staff Writer
INVISTA and SilicoLife, a computational biology company, have collaborated to develop new technologies that facilitate bio-derived processes for the production of industrial chemicals.
Production & Manufacturing > Fine & Speciality Chemicals > News
See more Fine & Speciality Chemicals news

Latest Fine & Speciality Chemicals News and Insight

View all Fine & Speciality Chemicals news or find news targeted to your interests
Lismore Comprehensive Represent Northern Ireland in Young Enterprise UK final
A group of innovative pupils from Lismore Comprehensive is representing Northern Ireland in London this week as they pitch their novel product in the UK final of the Young Enterprise Company of the Year competition.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
“Portadown Gets Active” A scheme to support local children and end holiday hunger
Children in Northern Ireland has just launched a scheme to support local children in Portadown. The programme is being delivered in partnership with the community and voluntary sector, statutory agencies, local schools and local government with additional support from Craigavon based Almac Group.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Group Announce US Workshops Targeting EU Product Launch Best Practices
Almac Group, the global contract development and manufacturing organisation, is delighted to announce two free, one-day exclusive knowledge sharing events titled "Almac Product Launch Workshop" on Tuesday, September 26th at the Andaz Hotel in San Diego, CA and on Thursday, September 28th at the DoubleTree by Hilton Hotel, Downtown Boston, MA.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
ALMAC: Innovative Electronic Patient Identification System: Reducing burden while improving site selection and study forecasts
In recent years, the clinical development function has been adopting software tools to improve productivity and speed study timelines. Yet, there are still pockets of opportunity for manual tasks to be automated and for paperwork to be digitised.
Production & Manufacturing > Fine & Speciality Chemicals > Case Studies
Almac Discovery is Granted Orphan Drug Designation for ALM201 Programme in Ovarian Cancer
Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its drug candidate ALM201 in the treatment of ovarian cancer.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor
– Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Debiopharm International SA, a Switzerland based speciality pharma company, today announced a collaboration to pursue the development of Almac Discovery’s Wee-1 kinase inhibitor programme.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Group Awarded U.S. Patent for Ground-breaking “DDRD” Assay
Almac Group’s Diagnostics business unit announced today it was granted intellectual property protection for its DNA Damage Response Deficiency (DDRD) assay.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Discovery Announce key Wee-1 kinase patent approval
Inhibitors of Wee-1 kinase, cell cycle regulator, have potential for clinical utility across a broad range of cancer indications
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
View all Fine & Speciality Chemicals news or find news targeted to your interests